A Phase II study of capecitabine and oxaliplatin combination chemotherapy in patients with inoperable adenocarcinoma of the gall bladder or biliary tract.
Phase of Trial: Phase II
Latest Information Update: 18 Mar 2016
At a glance
- Drugs Capecitabine (Primary) ; Oxaliplatin (Primary)
- Indications Biliary cancer; Gallbladder cancer
- Focus Therapeutic Use
- Acronyms BILXELOX
- 01 May 2010 New source identified and integrated (ISRCTN: Current Controlled Trials record no. 40839737).
- 05 Nov 2007 New trial record.